Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab

BACKGROUND: Immune related adverse events affecting various organ systems are a recognized potential consequence of immune checkpoint inhibition. However, autoimmune inner ear disease is one complication not previously associated with the use of checkpoint inhibitors, though it has been reported aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Zibelman, Matthew, Pollak, Natasha, Olszanski, Anthony J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754989/
https://www.ncbi.nlm.nih.gov/pubmed/26885370
http://dx.doi.org/10.1186/s40425-016-0114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754989/
https://www.ncbi.nlm.nih.gov/pubmed/26885370
http://dx.doi.org/10.1186/s40425-016-0114-4

Ejemplares similares